Article detail · 2024 · article
The epithelial barrier theory and its associated diseases
Data source split
- YÖKSİSYÖKSİS article record
- YÖKSİS venueALLERGY
- Catalog match (ISSN)Allergy: European Journal of Allergy and Clinical Immunology
- OpenAlexOpenAlex enrichment (abstract, citations, topics)
- Semantic Scholarcitation count (not merged with OpenAlex)
Abstract
The prevalence of many chronic noncommunicable diseases has been steadily rising over the past six decades. During this time, over 350,000 new chemical substances have been introduced to the lives of humans. In recent years, the epithelial barrier theory came to light explaining the growing prevalence and exacerbations of these diseases worldwide. It attributes their onset to a functionally impaired epithelial barrier triggered by the toxicity of the exposed substances, associated with microbial dysbiosis, immune system activation, and inflammation. Diseases encompassed by the epithelial barrier theory share common features such as an increased prevalence after the 1960s or 2000s that cannot (solely) be accounted for by the emergence of improved diagnostic methods. Other common traits include epithelial barrier defects, microbial dysbiosis with loss of commensals and colonization of opportunistic pathogens, and circulating inflammatory cells and cytokines. In addition, practically unrelated diseases that fulfill these criteria have started to emerge as multimorbidities during the last decades. Here, we provide a comprehensive overview of diseases encompassed by the epithelial barrier theory and discuss evidence and similarities for their epidemiology, genetic susceptibility, epithelial barrier dysfunction, microbial dysbiosis, and tissue inflammation.
Topics
Citations
OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.
158citationsOpenAlex · cited_by_count (cache / database)
29 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).
- 2025 Type 2 immunity in allergic diseasesCitations 345 · OpenAlex
- 2025 Type 2 immunity in allergic diseasesCitations 345 · OpenAlex
- 2025 Type 2 immunity in allergic diseasesCitations 326 · OpenAlex
- 2025 The Evolution, Immunopathogenesis and Biomarkers of Type 2 Inflammation in Common Allergic DisordersCitations 55 · OpenAlex
- 2025 The Evolution, Immunopathogenesis and Biomarkers of Type 2 Inflammation in Common Allergic DisordersCitations 55 · OpenAlex
- 2025 The Evolution, Immunopathogenesis and Biomarkers of Type 2 Inflammation in Common Allergic DisordersCitations 54 · OpenAlex
- 2024 Epithelial barrier dysfunction and associated diseases in companion animals: Differences and similarities between humans and animals and research needsCitations 26 · OpenAlex
- 2024 Epithelial barrier dysfunction and associated diseases in companion animals: Differences and similarities between humans and animals and research needsCitations 26 · OpenAlex
- 2024 Epithelial barrier dysfunction, type 2 immune response, and the development of chronic inflammatory diseasesCitations 24 · OpenAlex
- 2024 Epithelial barrier dysfunction, type 2 immune response, and the development of chronic inflammatory diseasesCitations 24 · OpenAlex